Status and phase
Conditions
Treatments
About
This is a dose-escalation and dose-expansion Phase 1 trial to evaluate the safety and tolerability of SHR-7367 in subjects with advanced solid tumors.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
182 participants in 1 patient group
Loading...
Central trial contact
Junshuang diao
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal